Because of the
industrialised nature of modern society, the implementation of many rights
protected at international and national law imply the provision of patented
products and products manufactured by a patented process.
The health of the individual may depend on the provision of certain
medicines or drugs which are protected by a patent and the manufacture and
sale of which are legally monopolised by the patent holder. It is the
potential conflict between the rights of the person to receive food or
medicine and the right of the patent holder to exercise a monopoly over the
patented product/process that defines the extent of the competing rights.
The conflicting duties of the state – to protect the rights of the patent
holder and the rights of the patient – define the obligations of states
under international law.
These conflicting duties
gave rise to the “flexibilities” within the original TRIPS agreement as it
was seen that individual states would have to determine for themselves in
what ways the conflict between the different rights were determined.
Musungu F (note 2 above) 211.
|